CBT vs SXT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

CBT

47.2
AI Score
VS
CBT Wins

SXT

44.7
AI Score

Investment Advisor Scores

CBT

47score
Recommendation
HOLD

SXT

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBT SXT Winner
Revenue 897.91M 2.73B CBT
Net Income 95.53M 147.00M CBT
Net Margin 10.6% 5.4% SXT
Operating Income 143.43M 356.00M CBT
ROE 7.6% 9.2% CBT
ROA 4.0% 3.7% SXT
Total Assets 2.37B 3.98B CBT
Cash 31.02M 250.00M CBT
Debt/Equity 0.61 0.52 CBT
Current Ratio 4.39 1.47 SXT
Free Cash Flow -32.67M 126.00M CBT

Relative Price Performance (Last 90 Days)

CBT 1M: -7.7% · 3M: -6.8% SXT 1M: -1.3% · 3M: +3.6%

Current Technical Phase

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.1%), weak momentum, RSI 38

RSI (14): 37.7 · Price: $79.68

SXT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.7 · Price: $128.60

Fundamentals Snapshot

Metric CBT SXT
Market Cap
Forward P/E 11.4 25.9
Trailing P/E 22.2 35.8
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.3%
Operating Margin 0.1% 0.2%
EPS 3.55 3.66
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CBT is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.